Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Pariente

Showing results (11-20 of 220) with videos related to

Pageof 22
Sort By:
Presse Medicale (Paris, France : 1983)|November 21, 2018
[Benzodiazepine use and misuse in France]Anne Bénard-Laribière, Antoine Pariente
American Journal of Hypertension|May 18, 2025
Effect of the COVID-19 epidemic on the association between antihypertensive drug interruption and the risk of major cardiovascular event in FranceClément Mathieu, Julien Bezin, Antoine Pariente
Frontiers in Pharmacology|May 31, 2023
Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysisClément Mathieu, Julien Bezin, Antoine Pariente
JAMA Psychiatry|December 18, 2014
Why are benzodiazepines not yet controlled substances?Nicholas Moore, Antoine Pariente, Bernard Bégaud
Lancet (London, England)|January 28, 2014
Linagliptin for elderly patients with type 2 diabetesFrancesco Salvo, Nicholas Moore, Antoine Pariente
Archives of Internal Medicine|June 12, 2013
Study findings hard to interpret-replyAntoine Pariente, Annie Fourrier-Réglat, Yola Moride
Therapie|June 6, 2017
False-positive results in pharmacoepidemiology and pharmacovigilanceJulien Bezin, Pauline Bosco-Levy, Antoine Pariente
Statistical Methods in Medical Research|April 27, 2016
Class-imbalanced subsampling lasso algorithm for discovering adverse drug reactionsIsmaïl Ahmed, Antoine Pariente, Pascale Tubert-Bitter
La Revue Du Praticien|December 5, 2018
Pharmacoepidemiology: how to assess medicines in real-life setting?Julien Bezin, Pauline Bosco-Levy, Antoine Pariente
Therapie|December 14, 2022
Systematic review on sex differences for drug use after strokeJulia Perrier, Mathilde Renard, Antoine Pariente, et al.
Pageof 22

Showing results (11-20 of 220) with videos related to

Sort By:
Pageof 22
Presse Medicale (Paris, France : 1983)|November 21, 2018
[Benzodiazepine use and misuse in France]Anne Bénard-Laribière, Antoine Pariente
American Journal of Hypertension|May 18, 2025
Effect of the COVID-19 epidemic on the association between antihypertensive drug interruption and the risk of major cardiovascular event in FranceClément Mathieu, Julien Bezin, Antoine Pariente
Frontiers in Pharmacology|May 31, 2023
Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysisClément Mathieu, Julien Bezin, Antoine Pariente
JAMA Psychiatry|December 18, 2014
Why are benzodiazepines not yet controlled substances?Nicholas Moore, Antoine Pariente, Bernard Bégaud
Lancet (London, England)|January 28, 2014
Linagliptin for elderly patients with type 2 diabetesFrancesco Salvo, Nicholas Moore, Antoine Pariente
Archives of Internal Medicine|June 12, 2013
Study findings hard to interpret-replyAntoine Pariente, Annie Fourrier-Réglat, Yola Moride
Therapie|June 6, 2017
False-positive results in pharmacoepidemiology and pharmacovigilanceJulien Bezin, Pauline Bosco-Levy, Antoine Pariente
Statistical Methods in Medical Research|April 27, 2016
Class-imbalanced subsampling lasso algorithm for discovering adverse drug reactionsIsmaïl Ahmed, Antoine Pariente, Pascale Tubert-Bitter
La Revue Du Praticien|December 5, 2018
Pharmacoepidemiology: how to assess medicines in real-life setting?Julien Bezin, Pauline Bosco-Levy, Antoine Pariente
Therapie|December 14, 2022
Systematic review on sex differences for drug use after strokeJulia Perrier, Mathilde Renard, Antoine Pariente, et al.
Pageof 22